{
  "slug": "nicotinamide-riboside",
  "version": "1",
  "displayName": "Nicotinamide riboside",
  "unit": "mg",
  "doseKind": "compound",
  "ingredientGroups": [
    "Nicotinamide riboside"
  ],
  "shelfComparable": true,
  "primaryFloorId": "nad-1000",
  "trialFloors": [
    {
      "id": "nad-1000",
      "label": "NAD+ elevation trial (1000 mg/day)",
      "presetLabel": "NAD+ trial",
      "amount": 1000,
      "frequency": "daily",
      "horizon": "6 weeks",
      "evidenceLevel": "limited",
      "palette": "research",
      "pmids": [
        "29599478"
      ],
      "n": 24,
      "note": "1000 mg/day for 6 weeks in a randomized double-blind crossover trial in healthy middle-aged and older adults; well-tolerated, elevated whole-blood NAD+. Cited in our urolithin A vs NMN guide, which covers the NAD+ booster shelf context.",
      "effectDirection": "secondary-only",
      "funding": "independent"
    }
  ],
  "guideSlugs": [
    "urolithin-a-vs-nmn"
  ],
  "guideUrls": [
    "https://supplementbrief.com/urolithin-a-vs-nmn/"
  ],
  "shelf": {
    "registrySlug": "nicotinamide-riboside",
    "label": "Nicotinamide riboside",
    "productCount": 171,
    "medianPerServing": 100,
    "p25PerServing": 2,
    "p75PerServing": 250,
    "belowPrimaryFloorPct": 99,
    "abovePrimaryFloorPct": 1,
    "unit": "mg",
    "generatedAt": "2026-09-27T19:07:29.098Z",
    "source": "NIH DSLD bulk CSV (DietarySupplementFacts)"
  },
  "updatedDate": "2026-09-27",
  "dosePageUrl": "https://supplementbrief.com/dose/nicotinamide-riboside/",
  "jsonUrl": "https://supplementbrief.com/data/v1/doses/nicotinamide-riboside.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/doses/nicotinamide-riboside/"
}
